Achieve Life Sciences Inc (ACHV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
Sales | 1,236 | 1,174 | 1,887 | 1,199 | 2,334 |
Gross Profit | 1,236 | 1,174 | 1,887 | 1,199 | 2,334 |
Operating Expenses | 9,208 | 5,271 | 6,880 | 6,424 | 4,249 |
Operating Income | -7,972 | -4,097 | -4,993 | -5,225 | -1,915 |
Other Income | -1,596 | 8,567 | -1,537 | 2,180 | -885 |
Pre-tax Income | -9,568 | 4,470 | -6,530 | -3,045 | -2,800 |
Net Income Continuous | -9,568 | 4,470 | -6,530 | -3,045 | -2,800 |
Net Income | $-9,568 | $4,470 | $-6,530 | $-3,045 | $-2,800 |
EPS Basic Total Ops | -2,178.22 | 1,012.10 | -1,474.15 | -682.07 | -572.06 |
EPS Basic Continuous Ops | -2,160.17 | 1,010.06 | -1,478.44 | -689.76 | -583.10 |
EPS Diluted Total Ops | -2,156.22 | 990.10 | -1,474.15 | -682.07 | -572.06 |
EPS Diluted Continuous Ops | -2,129.30 | 979.19 | -1,478.44 | -689.76 | -582.05 |
EBITDA(a) | $-7,953 | $-4,078 | $-4,975 | $-5,206 | $-1,902 |